Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 20, 2011
“We had several notable accomplishments during the quarter that illustrate progress toward strategic milestones,” said Ray Elliott, Company President and CEO.
-
Apr 14, 2011
Company will webcast its conference call with financial results and business highlights for Q1 2011 on April 21. Learn how to tune in.
-
Apr 5, 2011Innovative stent designed to treat peripheral vascular lesions for stenoses in arteries above the knee
Study will evaluate safety and effectiveness in patients with stenosis of the superficial femoral artery (SFA) or proximal popliteal artery (PPA).
-
Apr 4, 2011
Reduction of geographic miss and bail-out stenting observed with highly visible PROMUS Element Stent
-
Apr 3, 2011
Lower event rates for new alloy and stent design versus older drug-eluting stent model
-
Mar 29, 2011
Clinical presentations to include 12-month data on PROMUS Element™ Platinum Chromium Stent
-
Mar 24, 2011
New technology designed to improve lead anchoring speed and consistency for physicians
-
Mar 22, 2011
Company will provide an update on its Cardiology, Rhythm and Vascular (CRV) Group initiatives involving coronary stent and structural heart technologies
-
Mar 8, 2011
Company will participate in the healthcare conference on March 15. Learn how to watch the webcast or the replay.
-
Mar 7, 2011
Third-generation bare-metal stent offers improved acute performance in treating patients with coronary artery disease
-
Mar 3, 2011
Company adds innovative technology for atrial fibrillation patients with high stroke risk
-
Feb 17, 2011
Company's third-generation drug-eluting stents now available in rapidly growing market
-
Feb 16, 2011
Company will participate in the healthcare conference on March 2. Learn how to tune in.
-
Feb 15, 2011
New products expand treatment options for healthcare providers
-
Feb 15, 2011
Scholarship Fund Honors Company's Late Chief Medical and Scientific Officer
-
Feb 8, 2011
Journal of American College of Cardiology sub-analysis showed women received a greater clinical benefit from cardiac resynchronization therapy defibrillators (CRT-Ds) than men
-
Feb 3, 2011
New system integrates market-leading Renegade HI-FLO Microcatheter with high-torque Fathom-16 Steerable Guidewire for peripheral embolization procedures
-
Feb 1, 2011
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the fourth quarter and full year ended December 31, 2010, as well as net...
-
Jan 28, 2011
Complaint involves Guidant's conduct leading to its recalls of ICDs in 2005, before Boston Scientific’s 2006 acquisition of Guidant
-
Jan 27, 2011
Procedure performed as part of BLOCk-CTI clinical trial evaluating treatment of Type 1 atrial flutter
-
Jan 26, 2011
PLATINUM China trial to support Chinese regulatory approval of next-generation platinum chromium stent
-
Jan 24, 2011
Fourth-generation stent features bioabsorbable polymer and everolimus drug coating
-
Jan 19, 2011
Distribution agreement will allow Company to expand the service it offers customers in Japan
-
Jan 19, 2011
A live webcast and archived replay of this call will be available
-
Jan 19, 2011
Innovative left atrial appendage closure device offers alternative for patients with atrial fibrillation and strengthens Company's position in emerging structural heart markets